Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 3/2018

16.07.2018

Incidence and outcomes of catheter related thrombosis (CRT) in patients with acute leukemia using a platelet-adjusted low molecular weight heparin regimen

verfasst von: Kay T. Htun, Mabel J. Y. Ma, Agnes Y. Y. Lee

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Patients with acute leukemia frequently develop catheter-related thrombosis (CRT) despite concurrent thrombocytopenia. The incidence, treatment and outcomes of this complication are poorly documented. We undertook this study to determine the incidence of CRT in patients with acute leukemia and assess the safety and effectiveness of a treatment strategy using a platelet-adjusted low molecular weight heparin (LMWH) dosing protocol. Patients (18 years and older) with newly diagnosed acute leukemia from January 2014 to December 2015 who received central venous catheters were included. The clinical data were reviewed up to 12 months from acute leukemia diagnosis to capture objectively documented CRT events. The outcome events including recurrent venous thromboembolism (VTE), bleeding events, infectious or mechanical complications, and death were reported up to 3 months from the time of CRT diagnosis. The incidence of CRT among 214 patients was 10.7% (23 patients) in the first 12 months after acute leukemia diagnosis. Among 18 patients who were treated with anticoagulation, 14 (78%) received reduced LMWH dosing due to concurrent thrombocytopenia. There were no recurrent VTE episodes, but 3 patients experienced bleeding events while on anticoagulation. Fifteen patients (83%) completed a minimum of 3 months anticoagulation. Twelve patients (52%) experienced an infectious complication, which was the main reason for catheter removal. Deaths occurred in 2 patients, related to underlying acute leukemia during 3 months period following CRT. Symptomatic CRT is frequent in patients with acute leukemia. Platelet-adjusted LMWH dosing may be effective and well tolerated despite thrombocytopenia.
Literatur
2.
Zurück zum Zitat De Cicco M, Matovic M, Balestreri L, Panarello G, Fantin D, Morassut S, Testa V (1997) Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res 86:101–113CrossRefPubMed De Cicco M, Matovic M, Balestreri L, Panarello G, Fantin D, Morassut S, Testa V (1997) Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res 86:101–113CrossRefPubMed
5.
Zurück zum Zitat Cortelezzia A, Fracchiolla NS, Maisonneuve P, Moia M, Luchesini C, Ranzi ML, Monni P, Pasquini MC, Lambertenghi-Deliliers G (2003) Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures. Leuk Lymphoma 44:1495–1501. https://doi.org/10.3109/10428190309178770 CrossRefPubMed Cortelezzia A, Fracchiolla NS, Maisonneuve P, Moia M, Luchesini C, Ranzi ML, Monni P, Pasquini MC, Lambertenghi-Deliliers G (2003) Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures. Leuk Lymphoma 44:1495–1501. https://​doi.​org/​10.​3109/​1042819030917877​0 CrossRefPubMed
7.
9.
Zurück zum Zitat Castelli R, Ferrari B, Cortelezzi A, Guariglia A (2010) Thromboembolic complications in malignant haematological disorders. Curr Vasc Pharmacol 8:482–494CrossRefPubMed Castelli R, Ferrari B, Cortelezzi A, Guariglia A (2010) Thromboembolic complications in malignant haematological disorders. Curr Vasc Pharmacol 8:482–494CrossRefPubMed
11.
12.
Zurück zum Zitat Carrier M, Khorana AA, Zwicker JI, Noble S, Lee AY (2014) Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH: a reply to a rebuttal. J Thromb Haemost 12:116–117. https://doi.org/10.1111/jth.12444 CrossRefPubMed Carrier M, Khorana AA, Zwicker JI, Noble S, Lee AY (2014) Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH: a reply to a rebuttal. J Thromb Haemost 12:116–117. https://​doi.​org/​10.​1111/​jth.​12444 CrossRefPubMed
14.
Zurück zum Zitat van Rooden CJ, Rosendaal FR, Barge RM, van Oostayen JA, van der Meer FJ, Meinders AE, Huisman MV (2003) Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound. Br J Haematol 123:507–512CrossRefPubMed van Rooden CJ, Rosendaal FR, Barge RM, van Oostayen JA, van der Meer FJ, Meinders AE, Huisman MV (2003) Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound. Br J Haematol 123:507–512CrossRefPubMed
17.
Zurück zum Zitat Refaei M, Fernandes B, Brandwein J, Goodyear MD, Pokhrel A, Wu C (2016) Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters. Ann Hematol 95:2057–2064. https://doi.org/10.1007/s00277-016-2798-4 CrossRefPubMed Refaei M, Fernandes B, Brandwein J, Goodyear MD, Pokhrel A, Wu C (2016) Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters. Ann Hematol 95:2057–2064. https://​doi.​org/​10.​1007/​s00277-016-2798-4 CrossRefPubMed
23.
Zurück zum Zitat Kovacs MJ, Kahn SR, Rodger M, Anderson DR, Andreou R, Mangel JE, Morrow B, Clement AM, Wells PS (2007) A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 5:1650–1653. https://doi.org/10.1111/j.1538-7836.2007.02613.x CrossRefPubMed Kovacs MJ, Kahn SR, Rodger M, Anderson DR, Andreou R, Mangel JE, Morrow B, Clement AM, Wells PS (2007) A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 5:1650–1653. https://​doi.​org/​10.​1111/​j.​1538-7836.​2007.​02613.​x CrossRefPubMed
Metadaten
Titel
Incidence and outcomes of catheter related thrombosis (CRT) in patients with acute leukemia using a platelet-adjusted low molecular weight heparin regimen
verfasst von
Kay T. Htun
Mabel J. Y. Ma
Agnes Y. Y. Lee
Publikationsdatum
16.07.2018
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 3/2018
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1711-5

Weitere Artikel der Ausgabe 3/2018

Journal of Thrombosis and Thrombolysis 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.